Teradyne (TER) Cash & Equivalents (2009 - 2026)

Teradyne (TER) has reported Cash & Equivalents for 18 consecutive years, with $349.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 3.03% year-over-year to $349.5 million; the trailing twelve-month figure through Jun 2026 stood at $349.5 million (up 3.03% YoY), and the FY2025 full-year result was $293.8 million, down 46.91% from the prior year.
• Cash & Equivalents improved to $349.5 million in Q2 2026 per TER's latest filing, from $241.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $854.8 million in Q4 2022 and bottomed at $241.9 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $541.9 million across 5 years, with a median of $562.7 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents grew 8.96% in 2024, then sank 49.13% in 2026.
• Over 5 years, Cash & Equivalents stood at $854.8 million in 2022, then decreased by 11.37% to $757.6 million in 2023, then slipped by 26.96% to $553.4 million in 2024, then sank by 46.91% to $293.8 million in 2025, then gained by 18.99% to $349.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $349.5 million, $241.9 million, and $293.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.